 dna flow cytometri colorect carcinoma correl dna stemlin prognost indic dna flow cytometri fcm paraffin-embed tissu block colorect carcinoma crc forty-seven percent tumor aneuploidi diploid seventy-two percent patient aneuploid diploid group aliv mean follow-up month surviv site tumor locat duke stage serum cea level certain dna stemlin irrespect ploidi pattern serum cea level mortal poor surviv duke stage mortal forty-six percent patient lesion duke advanc stage adjuv therapi eighty-f percent subgroup patient patient aneuploid tumor role fcm assess prognosi crc clinic evalu random control trial